U S Department of Health and Human Services www.hhs.gov
  CMS Home > Medicare > Medicare Coverage - General Information > Medicare Coverage Database > View NCA

Medicare Coverage Database

NCA for Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration (CAG-00066R)


 
 Contacts

Stuart Caplan, RN
stuart.caplan@cms.hhs.gov
1-410-786-8564


 
 Documents
Tracking Sheet

Decision Memo

NCD for Ocular Photodynamic Therapy (OPT) (80.2)

NCD for Verteporfin (80.3)


 
 History of Considerations
Original consideration for Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration (CAG-00066N)

First reconsideration for Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration (this document)

Second reconsideration for Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration (CAG-00066R2)

Third reconsideration for Ocular Photodynamic Therapy with Verteporfin for Macular Degeneration (CAG-00066R3)


basket Add to basket  |  envelope icon - email Email this to a friend  |  new search New Search


Page Last Modified: 11/14/2008 11:16:12 AM

Help with File Formats and Plug-Ins

Submit Feedback





www1